NHS Launches Obe-cel: Hope for Aggressive Leukaemia Patients
NHS introduces ‘obe-cel’, a CAR T-cell therapy, offering a ‘hope of cure’ for aggressive leukaemia patients. This personalized ‘living drug’ achieved over 75% remission in trials.
NHS introduces ‘obe-cel’, a CAR T-cell therapy, offering a ‘hope of cure’ for aggressive leukaemia patients. This personalized ‘living drug’ achieved over 75% remission in trials.